Back to Search Start Over

Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia

Authors :
Wright, Stephen T.
Law, Matthew G.
Cooper, David A.
Keen, Phillip
McDonald, Ann
Middleton, Melanie
Woolley, Ian
Kelly, Mark
Petoumenos, Kathy
Source :
Journal of the International AIDS Society. January, 2015, Vol. 18 Issue 1
Publication Year :
2015

Abstract

Introduction: HIV prevention strategies are moving towards reducing plasma HIV RNA viral load in all HIV-positive persons, including those undiagnosed, treatment naive, on or off antiretroviral therapy. A proxy population for those undiagnosed are patients that present late to care with advanced HIV. The objectives of this analysis are to examine factors associated with patients presenting with advanced HIV, and establish rates of treatment interruption and modification after initiating ART. Methods: We deterministically linked records from the Australian HIV Observational Database to the Australian National HIV Registry to obtain information related to HIV diagnosis. Logistic regression was used to identify factors associated with advanced HIV diagnosis. We used survival methods to evaluate rates of ART initiation by diagnosis CD4 count strata and by calendar year of HIV diagnosis. Cox models were used to determine hazard of first ART treatment interruption (duration > 30 days) and time to first major ART modification. Results: Factors associated (p Conclusions: Recent HIV diagnoses are initiating therapy earlier in all diagnosis CD4 cell count groups, potentially lowering community viral load compared to earlier time periods. We found a marked reduction in the hazard of first treatment interruption, and found no difference in rates of major modification to ART by HIV presentation status in recent periods. Keywords: combination antiretroviral therapy; late diagnosis; advanced HIV diagnosis; treatment interruption; treatment modification.<br />Introduction Antiretroviral therapy (ART) is considered to be a life-long viable means to control HIV in patients and populations [1]. The introduction of fixed dose, once-a-day dosing and later generation [...]

Details

Language :
English
ISSN :
17582652
Volume :
18
Issue :
1
Database :
Gale General OneFile
Journal :
Journal of the International AIDS Society
Publication Type :
Academic Journal
Accession number :
edsgcl.435190590
Full Text :
https://doi.org/10.7448/IAS.18.1.19463